Menu

CME Corner

Active Programs

Preventing Hospital Readmissions in Heart Failure with Quality-Focused Learning

Quality performance measures for patients hospitalized with HF substantiate that there is room to improve the management and outcomes in this population. Recognizing that continuing medical education (CME) “supports the improvement of knowledge, confidence, and clinical performance among healthcare providers,” a CME program focused on improving HF readmission quality measures may have a substanti ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME
  • ACPE

Improving Clinician-Patient Collaboration in the Management of Obesity: A Patient Seeking Treatment for Obesity

Obesity is a chronic, complex disease with a significant economic burden that is associated with more than 200 other medical disorders that affect entire organ systems. The National Center for Health Statistics (NCHS) recently reported that the prevalence of obesity in US adults is nearly 40%. It is now recognized by the World Health Organization (WHO) as an epidemic, with an estimated 671 million ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Improving Clinician-Patient Collaboration in the Management of Obesity: A Patient with Diabetes who would Benefit from Weight Loss

Obesity is a chronic, complex disease with a significant economic burden that is associated with more than 200 other medical disorders that affect entire organ systems. The National Center for Health Statistics (NCHS) recently reported that the prevalence of obesity in US adults is nearly 40%. It is now recognized by the World Health Organization (WHO) as an epidemic, with an estimated 671 million ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Systemic Sclerosis Interstitial Lung Disease: Early Diagnosis and Comprehensive Management

Interstitial lung disease (ILD) is a frequent complication of the autoimmune disorder systemic sclerosis (SSc). SSc-ILD remains a challenging condition to identify, treat, and manage. Early identification of ILD in patients with SSc is critical so that treatment can be initiated as soon as possible. However, utilization of optimal screening and diagnosis strategies is low among healthcare provider ...

  • Online Presentation Online Presentation
  • ACCME

Precision Medicine in Severe Asthma: The Importance of Phenotypes and Endotypes in Patient Evaluation

Severe asthma affects only 3-6% of the overall population of asthmatics, but accounts for nearly half of the annual expenditures among asthma patients. Advances in the understanding of the pathophysiology of severe asthma have led to the identification of specific asthma endotypes and phenotypes that may be used to better tailor therapy in the future. This activity will explore the value of determ ...

  • Online Presentation Online Presentation
  • ACCME

Precision Medicine in Severe Asthma: How Phenotypes and Endotypes Guide Treatment Decisions

Despite advances in understanding the drivers of severe asthma, rates of hospitalization and mortality due to asthma have not changed significantly in the last two decades. It’s only recently as the medical community has become better at identifying specific asthma endotypes and phenotypes that we’ve seen the rise of unique therapies targeting specific disease pathways. This activity will break do ...

  • Online Presentation Online Presentation
  • ACCME

Addressing the Challenges of Progressive Multiple Sclerosis: Diagnosis and Management of Progressive MS

Progressive MS is characterized by a steadily increasing, objectively documented course of neurologic disability. The diagnosis of progressive forms of MS, primary progressive MS (PPMS) and secondary progressive MS (SPMS) can be challenging, and consequently many patients have untreated disease for years before they are appropriately diagnosed. Management can also be difficult due to the heterogen ...

  • Online Presentation Online Presentation
  • ACCME

Addressing the Challenges of Progressive Multiple Sclerosis: Cases in Progressive MS

Progressive MS is characterized by a steadily increasing, objectively documented course of neurologic disability. The diagnosis of progressive forms of MS, primary progressive MS (PPMS) and secondary progressive MS (SPMS) can be challenging, and consequently many patients have untreated disease for years before they are appropriately diagnosed. Management can also be difficult due to the heterogen ...

  • Online Presentation Online Presentation
  • ACCME

Early Diagnosis and Optimal Care of Ankylosing Spondylitis in Patients with Back Pain

Ankylosing spondylitis (AS), the most common spondyloarthropathy, is a chronic, progressive, debilitating inflammatory disease that affects about 1% of adults in the United States. AS often starts in young adulthood and has a substantial negative impact on physical functioning and quality of life. This activity will examine considerations for early recognition and guideline-driven treatment. ...

  • Online Presentation Online Presentation
  • ACCME

Diagnosing and Managing Parkinson's Disease in Older Adults

Parkinson’s disease (PD) is characterized by both motor and nonmotor symptoms. It is diagnosed based on the presence of two of four motor symptoms including rest tremor, bradykinesia, rigidity, and gait imbalance. Nonmotor symptoms include autonomic, olfactory, or cognitive dysfunction, as well as neuropsychiatric symptoms, including psychosis with hallucinations and delusions. Symptoms of PD can ...

  • Online Presentation Online Presentation
  • ACCME
  • ACPE
  • ANCC

Managing Chronic Heart Failure in Special Populations

This activity will address the management of heart failure (HF) in older adults, African Americans, patients with diabetes, and patients with poor renal function. ...

  • Online Presentation Online Presentation
  • ACCME
  • ACPE

Decoding Interstitial Lung Disease: Identifying and Managing Progressive Phenotypes

Interstitial lung disease (ILD) comprises more than 130 distinct lung disorders. Some forms of ILD, including connective tissue disease-associated ILD (CTD-ILD), chronic hypersensitivity pneumonitis (CHP), and fibrosing types of ILD such as fibrotic nonspecific interstitial pneumonia (fNSIP), follow a particularly aggressive course. This activity will address the timely identification and treatmen ...

  • Online Presentation Online Presentation
  • ACCME

Novel Targeted Agents in the Management of Recurrent Advanced Ovarian Cancer

Ovarian cancer is the fifth most common cause of cancer death in women in the United States. The majority of patients with ovarian cancer experience disease recurrence and receive second-line and sometimes several lines of therapy. Recurrent ovarian cancer is often resistant to chemotherapy, thus limiting the treatment options. Advances in technology and medical research have identified VEGF and P ...

  • Online Presentation Online Presentation
  • ACCME

The Value of Biosimilars in the Treatment of IBD: Frequently Asked Questions

Biosimilars offer additional treatment options for patients with IBD. In this activity, faculty will review the role of biosimilars in the management of IBD and answer learner questions from the previous activity (see "Related Programs" above). ...

  • Video Roundtable Video Roundtable
  • ACCME

Nursing Management of Treatment-Related Side Effects in Metastatic Prostate Cancer

Treatment for prostate cancer has expanded and improved in recent years, but many patients continue to live with the long-term sequelae of the disease and treatment-related side effects. There are numerous treatment options available for both hormone-sensitive and castration-resistant metastatic prostate cancer, and oncology nurses must be knowledgeable about these and their wide range of adverse ...

  • Online Presentation Online Presentation
  • AANP
  • ACCME
  • ANCC

Improving the Management of Severe Asthma in Patients with Type 2 Inflammation

This interactive case-based activity will examine factors contributing to severe asthma, the role of type 2 inflammation, and novel agents to manage severe asthma in patients with type 2 inflammation. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • AANP
  • AAPA
  • ACCME

Essential Strategies for Managing Psoriatic Arthritis

The underdiagnosis and undertreatment of psoriatic arthritis represents a significant healthcare gap that increases the potential for severe disease burden, including decreased physical function and quality of life. This interactive patient simulation will examine screening, diagnosis and evidence-based treatment options. ...

  • Online Presentation Online Presentation
  • ACCME

Type 2 Inflammation in Asthma: Considerations for Targeted Therapy

This interactive case-based activity will examine treatment strategies for uncontrolled type 2 asthma. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

The Value of Biosimilars in the Treatment of Inflammatory Bowel Disease

A number of biosimilars have been approved in recent years, offering additional treatment options for patients with IBD. Given the novelty of biosimilars in the U.S., it’s not surprising that clinicians have questions. In this activity, faculty will define biosimilars, examine how they’re studied and regulated, and discuss their current and potential role in IBD management, including how they migh ...

  • Video Roundtable
  • ACCME

Expired Programs

Clinical Insights in Pediatrics: Juvenile Idiopathic Arthritis--Diagnosis and Management in Primary Care

Juvenile idiopathic arthritis (JIA) is the most common chronic inflammatory arthritis in the pediatric population, affecting over 300,000 children and adolescents in the United States. The management of JIA represents a significant challenge to physicians, NPs, and other clinicians, particularly those in front-line specialties such as pediatrics and primary care. This activity will address timely ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Clinical Insights in Pediatrics: Type 2 Diabetes in Children and Adolescents with Obesity

The incidence and prevalence of obesity in children and adolescents has increased in recent years, and with it the incidence and prevalence of type 2 diabetes mellitus (T2DM). Compared with adults, T2DM in pediatric patients frequently progresses more rapidly, with high rates of early development of comorbidities and often with a less favorable response to treatment. The American Diabetes Associat ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Contemporary Management of Type 2 Diabetes

The management of type 2 diabetes (T2D) remains a clinical challenge as patients continue to struggle with achieving therapeutic goals. While there are many treatment options for T2D, there is relatively limited guidance on selection of second- and third-line treatments. This activity will review the most recent T2D treatment guidelines (including strategies for patient communication), and address ...

  • Online Presentation Online Presentation
  • ACCME

Evolving Standards of Care in Metastatic Prostate Cancer

For patients with metastatic prostate cancer (mPRCA), the number of metastases has prognostic and therapeutic implications. Clinicians who treat patients with mPRCA need to recognize patients with oligometastatic prostate cancer and be aware that management of patients with fewer than 5 metastases is different from that of patients with polymetastatic disease. Recommendations for the initial manag ...

  • Online Presentation Online Presentation
  • ACCME

Exploring the Role of Type 2 Inflammation in Uncontrolled Asthma

This interactive case-based activity will examine uncontrolled asthma and the role played by type 2 inflammation. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Identifying and Diagnosing Interstitial Lung Disease

An early and accurate diagnosis of ILD and its specific type is vital to directing therapy and monitoring disease course and therapeutic response, but these conditions are commonly mischaracterized, and a correct diagnosis is often delayed. This activity will examine strategies for identifying and accurately diagnosing ILD. ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

Idiopathic Pulmonary Fibrosis: Developing Evidence-Based Management Plans

Treatment of ILD can be a challenge for clinicians; poor outcomes and health-related quality of life attest to the significant care gaps and treatment limitations that remain. Advances in the treatment of ILD, and particularly in idiopathic pulmonary fibrosis (IPF), hold promise for improved care and patient outcomes. This activity will examine management strategies for IPF. ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

Managing Type 2 Diabetes: The Role of Insulin

Type 2 diabetes (T2D) is a chronic, highly prevalent disease. Despite the availability of many treatment options, including new insulin formulations that have the potential to simplify treatment regimens, improve treatment adherence, and provide clinical benefit, patients often have poor glycemic control. This activity will examine the role of insulin therapy in the management of T2D. ...

  • Online Presentation Online Presentation
  • ACCME
  • ACPE

Metastatic Colorectal Cancer: Applying Evidence-based Recommendations for Evaluation and Management

Colorectal cancer is the third most common cancer in men and women. Current evidence-based guidelines recommend that all metastatic colorectal tumors be tested for RAS mutations (both KRAS and NRAS) and BRAF mutations, as the presence of such mutations has implications for treatment. Clinical practice is variable, however, and many patients do not receive guideline-based care. This activity will e ...

  • Online Presentation Online Presentation
  • ACCME
  • ANCC

Strategies for Achieving LDL-C Goals to Reduce ASCVD Risk

There are numerous treatment options available for the management of familial hypercholesterolemia (FH) and non-familial hypercholesterolemia, but many patients remain unable to achieve optimal reductions in their LDL-C levels. This interactive case-based activity will examine the consequences of elevated LDL-C and explore strategies for achieving target LDL-C goals. ...

  • Online Presentation Online Presentation
  • ACCME

The Changing Landscape of Interstitial Lung Disease

Many patients with interstitial lung disease (ILD) do not receive a timely and accurate diagnosis prior to considerable disease progression. Management guidelines are vague and treatment options have been limited, leading to negative health outcomes and decreased quality of life. Advances in diagnostic strategies, recently approved therapies, and new clinical trial data, however, are changing best ...

  • Online Presentation
  • ACCME
Main Menu
EDITOR'S PICKS